Mitchell P. Kopin 13D and 13G filings for Can-Fite BioPharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 06:52 am Purchase | 2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Mitchell P. Kopin | 3,949,544 4.990% | 658,379 (+20.00%) | Filing |
| 2021-01-29 06:51 am Purchase | 2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Mitchell P. Kopin | 3,291,165 6.600% | 3,254,755 (+8939.10%) | Filing |